Krensavage Asset Management, LLC Biogen Inc. Transaction History

Krensavage Asset Management, LLC

$178 Million
Q3 2024

A detailed history of Krensavage Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 113,502 shares of BIIB stock, worth $17 Million. This represents 12.33% of its overall portfolio holdings.

Number of Shares

113,502

Previous 123,785 8.31%

Holding current value

$17 Million

Previous $28.7 Million 23.33%

% of portfolio

12.33%

Previous 13.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $1.94 Million - $2.44 Million	-10,283 Reduced 8.31%	113,502 $22 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $1.96 Million - $2.43 Million	-10,283 Reduced 7.67%	123,785 $28.7 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $5.6 Million - $7.07 Million	-26,412 Reduced 16.46%	134,068 $28.9 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $4.14 Million - $4.67 Million	-16,346 Reduced 9.24%	160,480 $41.2 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $82,575 - $95,418	-300 Reduced 0.17%	176,826 $50.4 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $31,300 - $35,665	122 Added 0.07%	177,126 $49.2 Million
Q4 2022 Feb 15, 2023	SELL	$252.44 - $306.72 $1.93 Million - $2.34 Million	-7,644 Reduced 4.14%	177,004 $49 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $13.1 Million - $18.1 Million	67,400 Added 57.48%	184,648 $49.3 Million
Q2 2022 Aug 16, 2022	BUY	$187.54 - $223.02 $1.11 Million - $1.31 Million	5,895 Added 5.29%	117,248 $23.9 Million
Q1 2022 May 17, 2022	BUY	$193.77 - $244.14 $1.61 Million - $2.03 Million	8,300 Added 8.05%	111,353 $23.5 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $33,364 - $42,877	-149 Reduced 0.14%	103,053 $24.7 Million
Q3 2021 Nov 16, 2021	BUY	$282.99 - $369.05 $1.61 Million - $2.1 Million	5,679 Added 5.82%	103,202 $29.2 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $10.6 Million - $17 Million	-40,995 Reduced 29.6%	97,523 $33.8 Million
Q1 2021 May 18, 2021	BUY	$242.95 - $284.63 $121,717 - $142,599	501 Added 0.36%	138,518 $38.8 Million
Q4 2020 Feb 17, 2021	BUY	$236.26 - $355.63 $201,766 - $303,708	854 Added 0.62%	138,017 $33.8 Million
Q3 2020 Nov 17, 2020	SELL	$264.77 - $305.71 $3.77 Million - $4.36 Million	-14,257 Reduced 9.42%	137,163 $38.9 Million
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $10.5 Million - $13.9 Million	40,649 Added 36.7%	151,420 $40.5 Million
Q1 2020 May 18, 2020	BUY	$268.85 - $341.04 $233,092 - $295,681	867 Added 0.79%	110,771 $35 Million
Q4 2019 Feb 18, 2020	SELL	$220.06 - $304.07 $14.7 Million - $20.3 Million	-66,806 Reduced 37.81%	109,904 $32.6 Million
Q3 2019 Nov 15, 2019	BUY	$217.44 - $243.88 $33,485 - $37,557	154 Added 0.09%	176,710 $41.1 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $755,234 - $832,483	-3,444 Reduced 1.91%	176,556 $41.3 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $39 Million - $61 Million	180,000 New	180,000 $42.5 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.

Account

Krensavage Asset Management, LLC Biogen Inc. Transaction History